Skip to main content
Clinical Trials/CTRI/2025/08/092542
CTRI/2025/08/092542Not yet recruitingNot Applicable

Application of Synthesis Repertory (Radar Opus 3.3 - Synthesis Treasure Edition) in treatment of chronic urticaria assessed by Urticaria Control Test - An Experimental Uncontrolled Study.

Dr M L Dhawale Memorial Homoeopathic Institute Palghar1 site in 1 country28 target enrollmentStarted: September 1, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
28
Locations
1
Primary Endpoint
To assess the action of indicated homoeopathic medicine as per Synthesis

Study Overview

Brief Summary

Chronic Urticaria is a mast cell-driven disease that is defined as the occurrence of wheals/hives or both twice in a week for more than 6 weeks due to known or unknown causes. It appears as raised erythematous skin lesions that are pruritic, evascent and worsened up by scratching.

It affects 15-20% of the population once or more during a lifetime. In around 30% patients of urticaria, attacks often recur for months or years.

As Urticaria comes under hypersensitive reaction of the skin, there is recurrence of symptoms within individuals. Here we have to assess recurrence of symptoms through its intensity and frequency. We can check it through the Urticaria Control Test scale.

The Urticaria Control Test is a questionnaire designed to determine if chronic urticaria is controlled or not and to aid therapeutic decision-making. Homoeopathy is useful in the treatment of Chronic Urticaria and hence I want to take this topic for study to understand the improvement in Chronic Urticaria on the Urticaria Control Test scale through Synthesis Repertory. In the end we will understand the usefulness of Synthesis Repertory in Chronic Urticaria.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
1.00 Year(s) to 18.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients who are diagnosed with chronic urticaria.
  • Patients of both sexes.
  • 18 year and above age group.
  • Patients who are taking anti-histaminic drugs for urticaria.

Exclusion Criteria

  • Patients who are taking immunomodulators for urticaria.
  • Other comorbidities like DM , HTN , Hypothyroidism.
  • Patient having presentation of angioedema with respiratory distress.

Outcomes

Primary Outcomes

To assess the action of indicated homoeopathic medicine as per Synthesis

Time Frame: 0 month i.e. before treatment , after 3 months of treatment and after 6 months of treatment.

Repertory in treatment of Chronic Urticaria assessed through Urticaria

Time Frame: 0 month i.e. before treatment , after 3 months of treatment and after 6 months of treatment.

Control Test.

Time Frame: 0 month i.e. before treatment , after 3 months of treatment and after 6 months of treatment.

Secondary Outcomes

  • To enlist common rubrics & prescribed homoeopathic medicines through(clinical cases of Chronic Urticaria.)

Investigators

Sponsor
Dr M L Dhawale Memorial Homoeopathic Institute Palghar
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Yogini Deepak Shirode

Dr M L Dhawale Memorial Homoeopathic Institute, Palghar

Study Sites (1)

Loading locations...

Similar Trials